New Delhi, The young contestant <keyword id="133007" type="General" weightage="20" keywordseo="jaskaran-singh" source="Orion">Jaskaran Singh</keyword>, who became the first crorepati on the 'Kaun Banega Crorepati' season 15, could not win Rs seven crore, as he failed to answer the question on Indian mythology. The 21-year-old Jaskaran, who hails from a small village Khalra, Punjab, which is at the cusp of the Indian border, aspires to become an IAS officer. In the episode 17th of the quiz-based reality show, hosted by megastar Amitabh Bachchan, Jaskaran won the hearts of the actor as well as the audience with his display of knowledge. However, after winning Rs one crore, Jaskaran was not able to answer the Rs seven crore question and he decided to quit the game. Big B lauded his decision to quit the game at the high risk point. The question of Rs 7 crore was: According to the Padma Purana, which king had to live as a tiger for a hundred years due to a deer's curse? The options given were- Kshemadhurti, Dharmadatta, Mitadhvaja and Prabhanjana. After reading the question, Jaskaran said: "Sir I have not heard of the them before. Mythologies such as the Mahabharata or Ramayana are on television. I have watched the shows B. R. Chopra's show Mahabharata and Ramanand Sagar's Ramayana. It's very difficult. I quit." The correct answer was 'Prabhanjana'. Speaking about the answer in detail, Big B said: "It's mentioned in the Puranas, that documents social, cultural, religious, and political views. This story is a part of Padma Purana. It goes like once upon a time, King Prabhanjana killed a deer, when she was feeding her child. The deer got upset and cursed King Prabhanjana to lead a tiger's life for 100 years." 'Kaun Banega Crorepati 15' airs on Sony. --IANS sp/svn

KBC 15 - After winning Rs 1 cr, Jaskaran fails to answer Rs 7 cr question on Indian mythology

<keyword id="874458" type="General" weightage="100" keywordseo="xiaomi" source="Orion">Xiaomi</keyword> on Monday announced a new visual identity for its premium range of products. With an aim to unify its global brand presence, its premium "Mi" series products will now be replaced with the new "Xiaomi" logo. With the new brand identity introduction, there will be two distinct product series under the parent corporate brand. The corporate brand will continue to be represented by the "Mi" logo. "Being a leading technology brand with a strong presence across the globe, our aim is to have a unified presence. With this new logo shift, we envision bridging the perception gap between our brand and products. "The new Xiaomi logo will be used for our premium products that represent the pinnacle of technology and offer a premium experience. Ushering in the festive season, Xiaomi's premium product series Mi will be renamed to Xiaomi'," <keyword id="10815895" type="General" weightage="20" keywordseo="jaskaran-singh-kapany" source="Orion">Jaskaran Singh Kapany</keyword>, Head of Marketing, Xiaomi India, said in a statement. The first Mi-branded smartphone, the Xiaomi Mi 1, was launched in August 2011, which makes the brand almost 10 years old. Over the years, the company launched tablets, TVs, smart devices, audio accessories, and more under the Mi brand. Xiaomi for the first time had surpassed Samsung and Apple to become the number one smartphone brand in the world in June, a Counterpoint Research report showed recently. Xiaomi's sales grew 26 per cent (month-on-month) in June, making it the fastest-growing brand for the month. Xiaomi was also the number two brand globally for Q2 2021 in terms of sales, and cumulatively, has sold close to 800 million smartphones since its inception in 2011, according to Counterpoint Research's 'Monthly Market Pulse Service'. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/news/google-reportedly-planning-to-release-android-12-stable-version-update-for-pixel-smartphones-on-october-4/articleshow/86165533.cms">Google reportedly planning to release Android 12 stable version update for Pixel smartphones on October 4</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/mobile/news/apple-iphone-12-series-smartphones-available-on-flipkart-with-big-discount/articleshow/86165082.cms">iPhone 12 gets a massive price cut on Flipkart ahead of the iPhone 13 launch</a>

You will no longer see 'Mi' on Xiaomi products as company officially drops decade old branding

<ul><li><keyword id="10815895" type="PERSON" weightage="20" keywordseo="jaskaran-singh-kapany">Jaskaran Singh Kapany</keyword>, Vice-President Marketing, <keyword id="6357120" type="DEFINITION" weightage="20" keywordseo="paytm">Paytm</keyword> will be moving on after being a part of the organization for 6 years. </li><li><keyword id="193898" type="PERSON" weightage="20" keywordseo="Abhinav-Kumar">Abhinav Kumar</keyword>, Vice President, Product Marketing at Paytm has been given the additional responsibility for now. </li></ul>Jaskaran Singh Kapany, Vice President - Marketing, Paytm will be moving on from the organization. The news was confirmed to us by a highly placed source in the industry on the condition of anonymity. With Kapany moving on, Abhinav Kumar, Vice President, Product Marketing at Paytm has been given the additional responsibility to handle the marketing portfolio for now, the source revealed. Kapany has been a part of Paytm for almost 6 years now and has been responsible for a lot of Paytm’s well-known campaigns. Prior to Paytm, he was VP, Marketing &amp; E-commerce, at <keyword id="75577" type="COMPANY" weightage="20" keywordseo="ICICI-Prudential-Life">ICICI Prudential Life</keyword> where he conceptualized the re-positioning of the master brand with the ‘Achche Bandeh’ corporate campaign. He has also been a part of JWT where he has worked on brands like Rin, Brylcreem, De Beers (DTC) and SBI Mutual Fund, amongst others.

Exclusive: Jaskaran Singh Kapany, Vice President - Marketing at Paytm moves on

<img class="gwt-Image" src="/photo/51822899.cms" style="width: 800px; height: 600px;" />When a boy named <keyword id="133007" type="PERSON" weightage="100" keywordseo="Jaskaran-Singh">Jaskaran Singh</keyword> from Delhi secured admission to Indian Institute of Management (IIM-B), Bangalore just two days ago, one person was super proud of his achievement - Mr <keyword id="3321960" type="UNKNOWN" weightage="100" keywordseo="Vaidyanathan-Singararaman">Vaidyanathan Singararaman</keyword>. 
 It was a Monday, and we were busy kick starting another new week, but Mr Singararaman wanted the world to stop and take notice of this boy. He took to his <keyword id="6354576" type="CITY" weightage="100" keywordseo="Facebook">Facebook</keyword> page to narrate what a remarkable day it was. One of hope, one of love and one to take inspiration from.. 
 He told us - Jaskaran, a student with Spinal Cord Injury at the cervical level, had become the first of his kind to make way into the Post Graduate Diploma in Business Management at one of the <keyword id="46923" type="ORGANIZATION" weightage="100" keywordseo="IIMs">IIMs</keyword> in the country. Basically, he is now an MBA student at <keyword id="60501" type="COMPANY" weightage="100" keywordseo="IIM-Bangalore">IIM Bangalore</keyword>. 
 
For a person who is paralysed neck down (a quadriplegic technically saying), one who can barely move his fingers and uses a custom made wireless keypad at work, it’s unbelievable that Jaskaran scored a whopping 99.04 per cent in CAT. We know what you are wondering... He wrote the exam with the help of a scribe. 
 
“This is an absolutely remarkable effort considering that CAT Organisers (IIM-A this year) did not accede to any of his essential requests,” Mr Singararaman’s <a href="https://www.facebook.com/photo.php?fbid=10209605867804555&amp;set=pcb.10209605902325418&amp;type=3">Facebook post read</a>. 
 
It’s not his injury, but his determination to fight against all odds and emerge as the winner that makes courageous people like him extremely SPECIAL for all of us. We cannot say it has been easy for Jaskaran to get to where he is today, we probably cannot even imagine the trials and tribulations in his life. But, things would have been little more difficult for him despite having cracked the entrance, had it not been for this man who fought the system 16 years back. 
 
We are talking of Mr Singararaman, the one who wrote the Facebook post on Jaskaran on Monday. He himself suffered a Spinal Cord Injury back in 1990 and was refused readmission by IIM Bangalore. 
<img class="gwt-Image" src="/photo/51812646.cms" /> (Right: Dr Suranjan with Mr Singararaman) 
"It took the efforts of Dr Suranjan Bhattacharji and my friends led by Elango Thambiah to change the mind of the management. IIM-B now is a leader in high quality access thanks to efforts spearheaded by Prof Rishikesha Krishnan, who is now the Director of IIM Indore," he says. 
 
If you are thinking about Mr Suranjan Bhattacharji, he is who changed minds in the college on denial of Mr Singararaman's readmission. A very highly regarded person in the top medicine-related places across the world, Mr Singararaman says Bhattacharji has made difference to several thousands of physically challenged persons across India. Now retired, he has gone to try and lift healthcare in a remote part of Orissa near the Niyamgiri Hills. 
 
It was probably this collective effort 16 years ago, that a deserving candidate today is not denied admission to an IIM on account of his/her health. Jaskaran, however, has done what many of us cannot do with our hands and feet fully functional. He is an inspiration for everyone. One person who he couldn't have done this without is - Divya Parashar, a Clinical Psychologist at Indian Spinal Injuries Centre. 
 
Call it a coincidence, but I was sitting with Mr Vipul Rastogi - a Behavioural Neurology and Psychiatry specialist at Medanta Hospital - today, and he pointed out to me the need for more Psychologists in our country. I relate it to this story, even though he spoke to me generally. He said: “We need more psychologists who can attend to patients suffering from such health problems. The problem is we don’t have enough psychologists, and when we refer our patients to consult them, patients refuse citing reasons that they are either busy and would prefer to have medicines prescribed or it’s an expensive deal for them. We need more such doctors who can hand hold such patients in their hour of need.” 
 
It seems Divya has set the example for more medical students to become Psychologists and make a difference. She played perhaps the most important role in Jaskaran’s life after his spinal cord injury in a road accident in which he lost his entire family. 
<img class="gwt-Image" src="/photo/51812600.cms" style="width: 800px; height: 600px;" /> 
More power to you, doctor! 
 
As for Jaskaran, you my friend, have given a nation it’s moment of pride.

The Inspiring Story Of Differently-Abled Jaskaran Singh Who scored 99% in CAT, and Secured Admission at IIM Bangalore

New Delhi, The quiz-based reality show '<keyword id="17940" type="General" weightage="20" keywordseo="Kaun-Banega-Crorepati" source="Orion">Kaun Banega Crorepati</keyword>' season 15, has got its second Crorepati in UP's <keyword id="18850842" type="General" weightage="20" keywordseo="Jasnil-Kumar" source="Orion">Jasnil Kumar</keyword>. The first Crorepati was Punjab's Jaskaran Singh. The 36-year-old Jasnil hails from Anwak in Uttar Pradesh, which is a small village in Azamgarh district. He works in a retail garment store. His family consists of mother, father, grandfather, his wife and two kids. He also has four younger brothers and two sisters. In episode 29 of the show, host and megastar <keyword id="6357912" type="General" weightage="20" keywordseo="Amitabh-Bachchan" source="Orion">Amitabh Bachchan</keyword> asked Jasnil: "Your current wish is to build a good house. Do you have any other wish?" To this, he replied: "Sir, like I told you, it's not like I don't think about myself. I had dreams as well as desires. When I was studying, I wished I had good clothes. l also wanted to travel." Big B said: "Both the wishes have been fulfilled. You travelled to Mumbai. You also got good clothes (indicating towards his jacket, which the actor gifted Jasnil)." Jasnil said: "We had financial problems at home from the beginning. My father's income was very meagre. I could manage somewhat after I got a job. With the money I earned, I tried to help my family, be it for farming or the education of my younger siblings." The actor wished him luck, saying: "Jasnil, may your desires be fulfilled. You have worked hard not just in your life but also in this game. Your innocence reflects in the way you talk, and depicts your roots. People of your region, your work and life experience have been innocent. And innocence matters in life. I believe so." Jasnil said: "As the elder son, I have to shoulder many responsibilities. Even if I try with this income, then it might take me a lifetime. KBC is a platform that can help me change my family's fortune overnight. Whatever prize money I win, I will use it to turn my house into a permanent structure." Then, the host asked him the question for Rs one Crore. The question read: "The gold left after a yagya performed by whom was used by the Pandavas to refill their treasury and conduct the Ashwamedha yagya?" The options given were - A: Vikarna B: Marutta C: Kubera D: Likhita. Jasnil gave the correct answer, which was Marutta, and won the huge price of Rs one crore. He then cried loudly in excitement, and hugged the 'Sholay' fame actor tightly. Jasnil even lied down on the floor, and touched Amitabh's feet in respect. Amitabh then asked him the last question for Rs seven crore: "Leena Gade, a person of Indian origin, is the first female race engineer to win which of the following races?" The options given were: A: Indianapolis 500 B: 24 Hours of Le Mans C: 12 Hours of Sebring D: Monaco Grand Prix. Jasnil guessed the right answer, which was option B - 24 Hours of Le Mans. However, he was not sure of the answer, and didn't have any lifelines left with him, so he decided to quit the show, and took home Rs one crore. Earlier, the show had its first Crorepati in Jaskaran Singh, who hails from a small village Khalra in Punjab, situated close to the border. However, after winning one crore Rupees, Jaskaran was not able to answer the Rs seven crore question and he decided to quit the game. Big B had lauded his decision to quit the game at the high risk point. The question of Rs seven crore asked to Jaskaran was: According to the Padma Purana, which king had to live as a tiger for a hundred years due to a deer's curse? The options given were Kshemadhurti, Dharmadatta, Mitadhvaja and Prabhanjana. The correct answer was Prabhanjana. 'Kaun Banega Crorepati 15' airs on Sony.

Jasnil Kumar who works in a garment store becomes KBC 15's second crorepati

(Eds: Updating after discharge of players from hospital and incorporating SAI statement) New Delhi, Aug 17 () Six Indian men's hockey team players, including skipper Manpreet Singh, were on Monday discharged from a Bengaluru hospital after recovering from COVID-19. The Sports Authority of India (SAI) said in a statement that Manpreet, defender Surender Kumar, Jaskaran Singh, Varun Kumar, goalkeeper Krishan Bahadur Pathak and striker Mandeep Singh have been placed under quarantine at its Bengaluru centre after they were discharged from the hospital. "Manpreet Singh, Surender Kumar, Jaskaran Singh, Varun Kumar, Krishan B Pathak and Mandeep Singh, who had tested Positive for COVID-19 earlier this month and were later shifted to hospital as a precautionary measure and for better monitoring were discharged from hospital earlier today," the SAI said. "They are now under quarantine at Sports Authority of India's National Centre of Excellence (NCOE) in Bengaluru." Speaking about the health condition of the players, Dr Arun Kumar of SS Sparsh Multispeciality hospital in Bengaluru said, "All the six players have recovered fully and their vitals are absolutely stable. "They will be in quarantine at SAI's Bengaluru centre and will be given the anti-body test after 10 days to check if they have built immunity against the virus." All the six players are housed in the ground floor of the hostel, where other members of the camp have no access, the SAI said. "This is a precautionary measure to ensure there is no contact between the six players and the other campers over the next 10 days." The SAI said the rest of the players of the Indian hockey teams, men and women, will resume sporting activities from Wednesday as scheduled. Earlier, a SAI source had told that all the six players have tested negative twice and their vitals are normal. They returned positive for the virus between August 10 and 12. "All the hockey players have completely recovered from COVID-19 and will be discharged this evening," the source said. Although asymptomatic, Mandeep was the first to be shifted to the hospital by the SAI after a dip in his blood oxygen level. Later, Manpreet and four other players were also moved to the same hospital as a precautionary measure. Currently, 33 male and 24 female players are in Bengaluru for the camp. The light intensity national camp is expected to continue till September 30. All the women players tested negative in the on-arrival tests conducted by SAI. SSC PM PDS AH

Hockey players discharged from hospital after recovering from COVID-19

New Delhi, Aug 17 () Six Indian men's hockey team players, including skipper Manpreet Singh, have recovered from COVID-19 and will be discharged from a Bengaluru hospital on Monday evening. According a source close to the team, Manpreet, defender Surender Kumar, Jaskaran Singh, Varun Kumar, goalkeeper Krishan Bahadur Pathak and striker Mandeep Singh have tested negative twice and their vitals are normal. They tested positive for the infection between August 10 and 12. "All the hockey players have completely recovered from COVID-19 and will be discharged this evening," the source told . Although asymptomatic, Mandeep was the first to be shifted to the SS Sparsh Multi-speciality Hospital in Bengaluru by the Sports Authority of India (SAI) after a dip in his blood oxygen level. Later, Manpreet and four other players were also moved to the same hospital as a precautionary measure. The training camps for both the men and women teams will begin in Bengaluru from Wednesday. However, the six recovered players will have to serve some more time in solation before they join their teammates. Currently, 33 male and 24 female players are in Bengaluru for the camp. The light intensity national camp is expected to continue till September 30. "But as per the state government guidelines the recovered players will have to live in isolation inside SAI campus for a week to 10 more days before resuming practice," the source said. All the women players tested negative in the on-arrival tests conducted by SAI. SSC PM PM

Hockey players recover from COVID-19; to be discharged from hospital this evening

Hash, India's first D2C millennial cigarette brand, announced today that it has raised close to US$ 3.5 mn (INR 25 crores) in recently concluded angel round. The round, that was led by Amrac Investment Trust, also saw participation by marquee angels - Kunal Shah (Founder, Cred, ex-Freecharge), Jitendra Gupta (Founder and CEO, Jupiter), Ashneer Grover (Co-Founder and Managing Director, BharatPe), Ankur Jain (Founder and CEO, Bira91), Anshoo Sharma (Co-Founder and CEO, <keyword id="3255375" type="PERSON" weightage="20" keywordseo="Magicpin">MagicPin</keyword>) and Suhail Sameer (Chief Executive Officer, BharatPe). Founded by <keyword id="5276331" type="PERSON" weightage="20" keywordseo="Shwetank-Jain">Shwetank Jain</keyword>, Hash is committed to empower the unorganized small retailers and paanwalas in the country through mobile-first tech products. Headquartered in Delhi-NCR, Hash is building disruptive technology-immersed products that will not only help digitize the businesses of paanwalas and small shopowners, but also build a more efficient supply chain and enable credit access to this segment, thereby boosting sales of its own brand Hash and other new age brands in the country. Shwetank holds a Masters in Management from <keyword id="5368204" type="ORGANIZATION" weightage="20" keywordseo="UCLA-University">UCLA University</keyword>, and has successfully built a Rs. 100 crores turnover home textile brand <keyword id="11852407" type="UNKNOWN" weightage="20" keywordseo="tapisserie">Tapisserie</keyword> in 3 years. The Hash team also includes seasoned professionals from the tobacco and FMCG industry including Mr. Jaskaran Singh Khurana, ex-Managing director for Golden Tobacco Limited. Speaking on the fund raise, Mr. Shwetank Jain, Founder, Hash, said, "Tobacco industry has a set of traditional players and aged brands. There is a large addressable market for freshly envisioned products targeted at millennials and distributed efficiently using technology. Also, there is urgent need to equip the millions of unorganized sellers and paanwalas with the latest technology solutions, so as to aid in their business growth and efficiency. With Hash, we are committed to empower this category of small shopowners and paanwalas." Added Mr. Kapil Chugh, Fund Promoter, Amrac Investment Trust, "Hash has the potential to do to tobacco what BIRA did to the alcobev industry. The interesting challenge is not only to introduce millennial first products, but at the same time change the way the product is distributed to lakhs of paanwaalas by disrupting supply chain using technology." Hash aims to build a team of 500+ professionals across levels, including feet on street sales force by the end of the current financial year. About Hash Hash, a new age D2C tobacco brand for the Gen Z and Millennials, was founded in the year 2021. The company aspires to be a market leader in Indian tobacco space by promoting its young products through digital supply chain solutions targeting the small shop owners and paanwalas. It is currently present in Delhi-NCR and will be expanding to other key cities in North India in the current fiscal year. It is committed to digitising the shops and lives of an everyday paanwalla, by building mobile based apps for smarter supply chain and business growth. In just 3 months of operation, the company has built a network of 1,000 small shop owners and paanwalas. SEE ALSO: <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/tech/mobile/news/iphone-13-series-to-reportedly-launch-with-bigger-batteries-and-improved-5g-support/articleshow/85297919.cms">iPhone 13 series to reportedly launch with bigger batteries and improved 5G support</a> <a target="_blank" class="c-link c-message_attachment__title_link" href="https://www.businessinsider.in/policy/news/pm-modi-launches-vehicle-scrappage-policy-aims-to-generate-35000-jobs-and-attract-10000-crore-investment/articleshow/85297011.cms">Indian government announces vehicle scrappage policy, aims to generate 35,000 jobs and attract ₹10,000 crore investment</a>

Cred's Kunal Shah, BharatPe, Bira91 founders invest in Hash

Pune has defeated Mumbai in a surprisingly close match. We all love those last ball matches. 
 All-rounder Hardik Pandya's last-over heroics helped <keyword id="13880" type="COMPANY" weightage="20" keywordseo="Mumbai-Indians">Mumbai Indians</keyword> recover from a mediocre position to post a healthy 184/8 against <keyword id="3315697" type="UNKNOWN" weightage="20" keywordseo="Rising-Pune-Supergiant">Rising Pune Supergiant</keyword> (RPS) in the second game of the 2017 Indian Premier League (IPL) at the Maharashtra Cricket Association Stadium here on Thursday. 
 
Bengal medium pacer Ashoke Dinda was the culprit for the home side conceding 30 runs in the final over when Hardik (35 not out) hammered the right-armer for four sixes (including three consecutive) and a four to change the course of the game. 
 
Earlier, South African leg-spinner Imran Tahir, who went unsold in the auctions and was a late addition to the Pune squad, brought the hosts back into the game with three quick wickets after the Mumbai opening duo of Jos Buttler (38) and Parthiv Patel (19) added 45 runs for the opening wicket. 
 
Introduced in the fifth over, Tahir struck in his second ball when he bowled Parthiv round his legs before packing Mumbai skipper Rohit Sharma (3) and Buttler in his next over to reduce Mumbai to 62/3. 
 
Rohit, who has been out of action for almost five months, was slow on his feet and it was enough for Tahir to break through his defence. One ball later, Tahir trapped the dangerous Buttler in front although television replays later showed that the Englishman had got a thick inside edge. 
 
Before his dismissal, Buttler lived up to his billing, milking his English teammate and IPL-10's costliest buy Ben Stokes (Rs 14.5 crore) for two consecutive sixes and then dispatching rookie Rajasthan medium-pacer Deepak Chahar for a four and a six off back-to-back deliveries. His 19-ball knock was laced with three hits to the fence and as many maximums. 
 
After the strategic time-out, Pune skipper Steve Smith introduced veteran all-rounder Rajat Bhatia, who responded well by taking a simple return catch to pack Ambati Rayudu (10) before dismissing Krunal Pandya (3) cheaply. 
 
Australian leggie Adam Zampa then added to the misery for the visitors by picking the crucial wicket of Nitish Rana (34), comfortably caught by Bhatia at deep midwicket. 
 
Rana looked good for his 28-ball knock, consisting a four and two sixes, but it was the 30-run fourth-wicket stand with Rayudu and 18 runs with Keiron Pollard (27) that mattered more. 
 Pollard, who was dropped by <keyword id="6397" type="PERSON" weightage="20" keywordseo="Dhoni">Dhoni</keyword> on 22, struggled to get the big shots before falling to a stunning running catch by Mayank Agarwal at the long-on boundary off Stokes. 
 
The West Indian struck three boundaries and a six in his 17-ball innings as he added 21 runs for the seventh wicket with Hardik Pandya. 
 
Hardik then added 37 runs for the eighth wicket with New Zealander Tim Southee (7) to put Mumbai in a commanding position. 
 
Brief Scores: Mumbai Indians 184/8 (Jos Buttler 38, Hardik Pandya 35 not out, Nitish Rana 34, Imran Tahir 3/28, Rajat Bhatia 2/14) vs Rising Pune Supergiant. 
 
Tweet Alert! 
 
<blockquote class="twitter-tweet" data-lang="en">
	
		.<a href="https://twitter.com/mipaltan">@mipaltan</a>'s <a href="https://twitter.com/RayuduAmbati">@RayuduAmbati</a> has been carried off on a stretcher <a href="https://twitter.com/hashtag/IPL?src=hash">#IPL</a> <a href="https://twitter.com/hashtag/RPSvMI?src=hash">#RPSvMI</a> <a href="https://t.co/SweaJoFJuM">pic.twitter.com/SweaJoFJuM</a>
	— IndianPremierLeague (@IPL) <a href="https://twitter.com/IPL/status/850043407519150080">April 6, 2017</a></blockquote>
<blockquote class="twitter-tweet" data-lang="en">
	
		Here's are the Playing XIs for <a href="https://twitter.com/RPSupergiants">@RPSupergiants</a> vs. <a href="https://twitter.com/mipaltan">@mipaltan</a> <a href="https://twitter.com/hashtag/IPL?src=hash">#IPL</a> <a href="https://twitter.com/hashtag/RPSvMI?src=hash">#RPSvMI</a> <a href="https://t.co/ZxbitEMi1c">pic.twitter.com/ZxbitEMi1c</a>
	— IndianPremierLeague (@IPL) <a href="https://twitter.com/IPL/status/849988305039093760">April 6, 2017</a></blockquote>
<blockquote class="twitter-tweet" data-lang="en">
	
		Match 2. Rising Pune Supergiant win the toss and elect to field <a href="https://t.co/klZJdA0cfH">https://t.co/klZJdA0cfH</a> <a href="https://twitter.com/hashtag/RPSvMI?src=hash">#RPSvMI</a>
	— IndianPremierLeague (@IPL) <a href="https://twitter.com/IPL/status/849985357882023938">April 6, 2017</a></blockquote>
<blockquote class="twitter-video" data-lang="en">
	
		Introducing - <a href="https://twitter.com/RPSupergiants">@RPSupergiants</a> <a href="https://twitter.com/hashtag/Smithy?src=hash">#Smithy</a> <a href="https://twitter.com/hashtag/MSDhoni?src=hash">#MSDhoni</a> <a href="https://twitter.com/hashtag/Stokes?src=hash">#Stokes</a> <a href="https://twitter.com/hashtag/Rahane?src=hash">#Rahane</a> <a href="https://twitter.com/hashtag/IPL?src=hash">#IPL</a> <a href="https://t.co/puERcj6iDt">pic.twitter.com/puERcj6iDt</a>
	— IndianPremierLeague (@IPL) <a href="https://twitter.com/IPL/status/849978012573499399">April 6, 2017</a></blockquote>
<blockquote class="twitter-tweet" data-lang="en">
	
		Play Hard, Play Fair - Spirit of Cricket at <a href="https://twitter.com/hashtag/IPL?src=hash">#IPL</a> - <a href="https://twitter.com/stevesmith49">@stevesmith49</a> and <a href="https://twitter.com/ImRo45">@ImRo45</a> <a href="https://t.co/UwPVL8CYih">pic.twitter.com/UwPVL8CYih</a>
	— IndianPremierLeague (@IPL) <a href="https://twitter.com/IPL/status/849975132819009536">April 6, 2017</a></blockquote>
<blockquote class="twitter-tweet" data-lang="en">
	
		We are in Pune today for <a href="https://twitter.com/RPSupergiants">@RPSupergiants</a> vs. <a href="https://twitter.com/mipaltan">@mipaltan</a>. Match starts at 8 PM IST <a href="https://twitter.com/hashtag/IPL?src=hash">#IPL</a> <a href="https://t.co/evncMJFLRQ">pic.twitter.com/evncMJFLRQ</a>
	— IndianPremierLeague (@IPL) <a href="https://twitter.com/IPL/status/849973121784393730">April 6, 2017</a></blockquote>
 
Complete squads: 
 
Rising Pune Supergiant 
 
Steve Smith (C), Mayank Agarwal, Ankit Sharma, Baba Aparajith, Ankush Bains, Rajat Bhatia, Deepak Chahar, Rahul Chahar, Dan Christian, <keyword id="6354832" type="ORGANIZATION" weightage="20" keywordseo="MS-Dhoni">MS Dhoni</keyword> (w), Ashok Dinda, Faf du Plessis, Lockie Ferguson, Imran Tahir, Jaskaran Singh, Usman Khawaja, Ajinkya Rahane, Saurabh Kumar, Ben Stokes, Milind Tandon, Manoj Tiwary, Adam Zampa, Jaydev Unadkat, Ishwar Pandey, Rahul Tripathi, Shardul Thakur. 
 
Mumbai Indians 
 
Rohit Sharma (C), Jasprit Bumrah, Jos Buttler, Shreyas Gopal, Krishnappa Gowtham, Asela Gunaratne, Harbhajan Singh, Mitchell Johnson, Kulwant Khejroliya, Siddhesh Lad, Mitchell McClenaghan, Lasith Malinga, Hardik Pandya, Krunal Pandya, Parthiv Patel (wk), Kieron Pollard, Nicholas Pooran, Deepak Punia, Nitish Rana, Ambati Rayudu, Jitesh Sharma, Karn Sharma, Lendl Simmons, Tim Southee, Jagadeesha Suchith, Saurabh Tiwary, Vinay Kumar.

IPL 2017, Pune vs Mumbai: Pune defeat Mumbai in a last ball clincher

<div class="KonaFilter image-container display-table"><div><div class="image on-image"><img src="https://static-ssl.businessinsider.com/image/5a2ed5378a4986b0008b5252-971/screen shot 2017-12-11 at 105611 am.png" border="0" alt="man silhouette alone sunrise sunset" data-mce-source="Daiana Lorenz/Youtube" />Daiana Lorenz/Youtube</div></div></div><ul><li><a href="http://www.businessinsider.com/category/ketamine">Ketamine</a> is emerging as a potential new drug for depression - the first of its kind in 35 years.</li><li>Johnson &amp; Johnson is actively pursuing a nasal formulation of the drug. Researchers plan to present the results of an advanced clinical trial of the formula next month at the American Psychiatric Association meeting.</li><li>An early glimpse at some of the results suggests that the formula is safe and linked with sustained improvements in depressive symptoms over a year. </li></ul><hr /> Ketamine, which has been called "<a href="http://science.sciencemag.org/content/338/6103/68.full">the most important discovery in half a century</a>," just got a step closer to becoming the first new drug for depression in 35 years.The compound has a reputation as a party drug, but many experts say that's unfair, since ketamine is increasingly being studied for its potential use as a rapid-fire treatment for depression.In people who live with the disease, thoughts of suicide can strike suddenly and without warning. Fast-acting, successful interventions are hard to come by. But a spate of recent research suggests ketamine could provide quick and powerful relief - even to people whose depression has repeatedly failed to respond to other medications, as well as to individuals who are suicidal.The promising studies on the treatment so far have come with one important caveat, however: the drug has to be taken intravenously, or via an injection, over roughly 45 minutes. That makes it a lot harder to get and take than a typical antidepressant pills such as Lexapro.With that in mind, Johnson &amp; Johnson company Janssen Research and Development has been actively pursuing the development of a formulation of the drug that would be safe and more convenient to administer. They're not alone: Allergan is in the last phase of clinical trials with a drug that <a href="https://www.fiercebiotech.com/regulatory/allergan-s-depression-drug-bags-a-breakthrough-tag-on-way-to-phase-iii">acts on the same receptor as ketamine</a>.Yet Johnson &amp; Johnson may be the furthest ahead in its research. The company <a href="https://www.jnj.com/media-center/press-releases/esketamine-recieves-breakthrough-therapy-designation-from-us-food-and-drug-administration-for-major-depressive-disorder-with-imminent-risk-of-suicide">received breakthrough therapy designation</a> for its nasal formulation from the US Food and Drug Administration in 2016, an elite and competitive status that is designed to speed the drug through the complex federal approval process.Earlier this month, the company shared with Business Insider some early results of a clinical trial of the nasal-spray formulation of the drug. The results suggest that the formula is well-tolerated by patients and linked with long-lasting improvements in depressive symptoms.<h2>The promising <keyword id="41551" type="ENTERTAINMENT" weightage="100" keywordseo="science">science</keyword> on ketamine</h2>Ketamine's utility as an antidepressant has recently started to gain attention.A recent <a href="https://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2017.17060647">study out of Columbia University Medical Center</a> found that ketamine worked significantly better at curbing suicidal thoughts in depressed patients than a commonly used sedative.A spate of other studies over the past several years have suggested that ketamine may <a href="http://www.businessinsider.com/ketamine-for-depression-2017-5">provide swift and powerful relief</a> to people suffering from some of the hardest-to-treat forms of depression - an illness that is the <a href="http://www.who.int/mediacentre/factsheets/fs369/en/">leading disability worldwide</a>. However, most studies of ketamine for depression have only lasted several weeks, which makes it difficult to say whether the drug has long-lasting potential. But Johnson &amp; Johnson's clinical trial took place over nearly a year. Additionally, rather than addressing people's depression with ketamine alone, the researchers gave them the ketamine nasal spray along with an oral antidepressant.Data from their clinical study - which used esketamine, the chemical mirror image of ketamine - suggest that patients tolerated the drug well. Most importantly, the treatment was also linked with sustained improvements in depressive symptoms over more than 11 months - making it one of the longest-lasting studies of ketamine to date."Janssen is committed to developing esketamine for treatment-resistant depression, a serious biological illness with high unmet need," Jaskaran Singh, Janssen's senior director of clinical research in its neuroscience therapeutics area, said during a presentation of the results on March 23 in Oxford.Their research currently is focused on people with one of the hardest to treat forms of depression (known as treatment-resistant depression). But company representatives told Business Insider that they also have plans to study the formula in adults and teens with major depressive disorder who are at imminent risk for suicide.<h2>How ketamine is being administered now</h2><div class="KonaFilter image-container display-table float_right"><div><div class="image on-image"><img src="https://static-ssl.businessinsider.com/image/5a00b37558a0c1ec0f8b52f9-1200/sfketamineclinic1.jpg" border="0" alt="sf ketamine clinic" data-mce-source="Erin Brodwin / Business Insider" />Erin Brodwin / Business Insider</div></div></div>After a 45-minute infusion of ketamine, clients at a clinic in San Francisco's Nob Hill neighborhood are not partying.Instead, they're in a state of quiet contemplation - reclining on cushioned chairs, listening to music, or occasionally striking a tranquil yoga pose.These clients are patients at one of 10 ketamine clinics operated by Actify Neurotherapies, a network that offers the drug via intravenous injection to people diagnosed with severe forms of anxiety and depression.While ketamine is a powerful dissociative that can induce feelings of being separated from one's own body, it is also <a href="http://www.who.int/medicines/news/20160309_FactFile_Ketamine.pdf">one of the safest and most widely used legal anesthetics</a>. Because the drug is federal approved for anesthesia, Actify - along with an estimated 50 to 100 other providers across the US - are legally able to administer it for depression.But using it for depression is considered "off-label" since that application of the drug is not outlined in its federally-approved designation. That means many patients must pay for the treatments out of pocket. Some insurance companies may reimburse some of the cost, but many do not. And the treatments aren't cheap - they typically <a href="https://www.medscape.com/viewarticle/886750#vp_1">range from $400 to $1,000 per infusion</a>; at Actify, they are $570 each.<a href="http://www.businessinsider.com/ketamine-depression-research-2017-12">At Actify's San Francisco office</a>, each two-hour visit includes 45 minutes of ketamine infusion, 45 minutes of a saline drip, and a consultation with <a href="https://ktcpartnership.com/san-francisco-ca/">Alison McInnes</a>, a physician who founded a regional ketamine therapy program with Kaiser Permanente. Most patients receive 10 infusions over the course of 10 weeks - three in the first week, two in the second, and one infusion in the third, fourth, and fifth weeks. The last two infusions are spread between weeks seven and 10."These are people who've been sick for decades and heard from multiple doctors that there's nothing else they can do," <a href="https://ktcpartnership.com/about-us/">Steve Levine</a>, a psychiatrist and the CEO of Actify, <a href="http://www.businessinsider.com/ketamine-depression-research-2017-12">told Business Insider during a recent visit to the clinic</a>. "We're enabling them to get back to their normal lives."<h2>A wave of hope from experts</h2>Experts who study depression say they're onto something promising with ketamine. In a field that hasn't seen a new class of drugs in nearly four decades - and in which patients are often desperate and suicidal - that kind of sentiment holds a lot of weight."Imagine arriving in the emergency room with severe pain from a kidney stone - pain so bad that you can't think. You'll do anything to make it go away. And the doctors say, 'here's a drug that we've been using for 30 years, it works 50-60% of the time, and it should start to work in 4-6 weeks'" <a href="http://www.massgeneral.org/doctors/doctor.aspx?id=18473">Cristina Cusin</a>, a psychiatrist at Massachusetts General Hospital and an assistant professor at Harvard University, <a href="http://www.businessinsider.com/depression-medication-treatment-ketamine-2018-2">told Business Insider in March</a>. For someone who is suicidal, "that's currently the best we can do," she said. Cusin co-authored a <a href="http://www.businessinsider.com/depression-medication-treatment-ketamine-2018-2">large recent review of the existing research on ketamine</a> that was published in March in the Harvard Review of Psychiatry. Her findings shed light on the need for new treatments, but she also advises caution for patients."We are just scratching the surface of the mechanisms of action with ketamine," Cusin said. "In the next few years I'm really hopeful that we're going to see new drugs that are completely different than what we have now." Don Mordecai, Kaiser Permanente's national leader for mental health, echoed some of Cusin's sentiment. Despite many questions about how to determine the right dose of ketamine and how long its benefits might last, Mordecai's overall assessment seems positive."There's still enough there to be excited about its potential," he said. <div class="margin-top"> <h3>NOW WATCH: <a href="http://www.businessinsider.com/how-humans-evolved-to-be-best-endurance-runners-2018-3">How humans evolved to become the best runners on the planet</a></h3> <div> <iframe class="bijwplayerclass" data-player="jwplayer" src="https://content.jwplatform.com/players/YB1ol1QX-CEZHWCBG.html" width="100%" height="100%" frameborder="0" scrolling="auto" style="margin:0px;" allowfullscreen=""></iframe><script>function receiveMessage(event){ console.log(event.data.fullscreen); Android.fullscreen(event.data.fullscreen); }window.addEventListener("message", receiveMessage, false);</script> </div> </div>

You Searched For "jaskaran singh" and got 10 results

KBC 15 - After winning Rs 1 cr, Jaskaran fails to answer Rs 7 cr question on Indian mythology

IANS

You will no longer see 'Mi' on Xiaomi products as company officially drops decade old branding

IANS

Exclusive: Jaskaran Singh Kapany, Vice President - Marketing at Paytm moves on

Samarpita Banerjee

The Inspiring Story Of Differently-Abled Jaskaran Singh Who scored 99% in CAT, and Secured Admission at IIM Bangalore

Anushree Singh

Jasnil Kumar who works in a garment store becomes KBC 15's second crorepati

IANS

Hockey players discharged from hospital after recovering from COVID-19

PTI

Hockey players recover from COVID-19; to be discharged from hospital this evening

PTI

Cred's Kunal Shah, BharatPe, Bira91 founders invest in Hash

PTI

IPL 2017, Pune vs Mumbai: Pune defeat Mumbai in a last ball clincher

Gaurav Sangwani

Ketamine could become the first new depression drug in more than 30 years

Erin Brodwin